On the eve of World Cancer Day, we were excited to welcome the Governor-General, His Excellency General the Honourable Sir Peter Cosgrove AK MC (Retd), and Her Excellency Lady Cosgrove.

The Governor-General and Lady Cosgrove were visiting cancer research and care facilities in Sydney and visited the Institute to meet those on the front line of childhood cancer research.

Their Excellencies were welcomed by Professor Michelle Haber AM, our Executive Director. Professor Haber told 20 gathered scientists that Sir Peter and Lady Cosgrove have been patrons of childhood cancer research at Children’s Cancer Institute over many years. She described their work with us as a “long journey of support”.

The Governor-General commended the significant advances being made by medical research institutes working together in the fight against cancer. He and Lady Cosgrove then met some of our scientists, from first-year PhD students to senior researchers.

Their Excellencies Sir Peter and Lady Cosgrove meet some of our researchers
Their Excellencies Sir Peter and Lady Cosgrove meet some of our research leaders

His Excellency was previously at the Institute in September last year when he officially opened the new ACRF Child Cancer Personalised Medicine Centre and toured our laboratories. Today he was able to talk one-on-one with the scientists about the work they do, and to share their enthusiasm and determination to find a cure for childhood cancer.

Following their visit, Their Excellencies toured Kids’ Cancer Centre at Sydney Children’s Hospital, Randwick who are leaders with us of the Zero Childhood Cancer personalised medicine program.

Read more about World Cancer Day.

Top image: Their Excellencies met PhD students Jixuan (Jessie) Gao and Christine Gana on their World Cancer Day visit.



Sign up for blog updates!

Every month, get a list of the latest posts in your inbox.

Thank you for subscribing.

Something went wrong.

Sign up for blog updates!

Every month, get a list of the latest posts in your inbox.

Thank you for subscribing.

Something went wrong.

Send this to a friend